Showing 1851-1860 of 21419 results for "".
- Inflammation and Pain in Neurocritical Care: New Insights from Recent Researchhttps://reachmd.com/news/inflammation-and-pain-in-neurocritical-care-new-insights-from-recent-research/2484056/A recent study found that early systemic inflammatory markers did not predict ICU pain burden after aneurysmal subarachnoid hemorrhage (SAH); instead
- Demographic Considerations in Diagnosing Interstitial Ectopic Pregnancyhttps://reachmd.com/news/demographic-considerations-in-diagnosing-interstitial-ectopic-pregnancy/2484074/A new retrospective study out of Boston Medical Center has shed light on a persistent diagnostic challenge in reproductive medicine: the misdiagnosis of interstitial ectopic pregna
- How Global Trade and Travel Influence Mosquito-Borne Disease Spreadhttps://reachmd.com/news/how-global-trade-and-travel-influence-mosquito-borne-disease-spread/2484076/According to a recent report, a global analysis maps how trade and travel have driven introductions of non-native mosquitoes since 1950 and id
- Innovative Management of Larotrectinib Withdrawal Symptoms Using GLP-1 Receptor Agonistshttps://reachmd.com/news/innovative-management-of-larotrectinib-withdrawal-symptoms-using-glp-1-receptor-agonists/2484079/A recent case report describes resolution of larotrectinib withdrawal symptoms after starting semaglutide, a GLP‑1 receptor agonist — an observation with immediate relevance for supportive care teams. The patient developed diffuse, withdrawal‑like myalgias and arthralgias in the set
- Interim Phase 2 Data Reveal Efficacy and Strategic Potential of KYV-101 in Generalized Myasthenia Gravishttps://reachmd.com/news/interim-phase-2-data-reveal-efficacy-and-strategic-potential-of-kyv-101-in-generalized-myasthenia-gravis/2484058/Interim Phase 2 data from Kyverna Therapeutics’ KYSA‑6 study indicate KYV‑101 produced early efficacy signals and an acceptable safety profile in generalized myasthenia gravis (gMG). KYV‑101 is a fully human, autologous CD19 CAR T‑cell therapy intended to induce deep
- ICONIC-TOTAL: Icotrokinra Shows Skin Clearance in Difficult-to-Treat PsO at 1 Yearhttps://reachmd.com/news/iconic-total-icotrokinra-shows-skin-clearance-in-difficult-to-treat-pso-at-1-year/2484061/Icotrokinra, a novel oral IL-23 inhibitor, was associated with imporvements in plaque psoriasis in difficult-to-treat areas of the body, according to new data presented at 2025 Fall Clinical Dermatology Conference in Las Vegas.
- AI System Identifies Surgical Phases in Robot-Assisted Prostatectomy Across Multiple Surgeonshttps://reachmd.com/news/ai-system-identifies-surgical-phases-in-robot-assisted-prostatectomy-across-multiple-surgeons/2484044/Researchers at Keio University School of Medicine have developed and validated an artificial intelligence (AI) model for automated recognition of surgical phases in robot-assisted radical prostatectomy (RARP). The
- Dual-Energy CT Enhances Image Quality for Liver Metastases Without Increasing Detectionhttps://reachmd.com/news/dual-energy-ct-enhances-image-quality-for-liver-metastases-without-increasing-detection/2484047/A recent retrospective study has evaluated the clinical performance of dual-energy CT (DECT) in imaging hypovascular liver metastases, focusing on image quality and diagnostic utility. Condu
- Systemic Inflammation Markers: No Predictor for Pain in SAHhttps://reachmd.com/news/systemic-inflammation-markers-no-predictor-for-pain-in-sah/2484052/A recent multicenter study found that early systemic inflammatory markers did not predict subsequent ICU pain burden after aneurysmal subarachnoid hemorrhage (SAH), a finding
- Harnessing Radiomics: Enhancing Prognosis in Pulmonary Embolism via Thrombus Imaginghttps://reachmd.com/news/harnessing-radiomics-enhancing-prognosis-in-pulmonary-embolism-via-thrombus-imaging/2484057/A new primary study identifies CT-derived thrombus radiomics as a robust prognostic tool, demonstrating that thrombus imaging materially improves ris